Alex Dipper
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 6
-
- Pleural and Pulmonary Diseases 3
- Occupational and environmental lung diseases 1
- Co-authors
- Nick A. Maskell (3 shared papers)Anna C. Bibby (1 shared paper)Amelia O. Clive (1 shared paper)Hayley E. Jones (1 shared paper)Nancy J Preston (1 shared paper)Rahul Bhatnagar (1 shared paper)Hugh G. Welch (1 shared paper)
- Journals
- The Lancet (6 papers)Thorax (1 paper)Cancers (1 paper)European Respiratory Review (1 paper)Archivos de Bronconeumología (1 paper)
- Partner nations
- United KingdomVietnamNepal
In The Last Decade
Alex Dipper
9 papers receiving 1.6k citations
Alex Dipper's Hit Papers
Peers
Comparison fields: 5 of 79
- Infectious Diseases 1.3k
- Applied Microbiology and Biotechnology 35
- Internal Medicine 27
- Statistics and Probability 45
- Oncology 75
Countries citing papers authored by Alex Dipper
This map shows the geographic impact of Alex Dipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alex Dipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alex Dipper more than expected).
Fields of papers citing papers by Alex Dipper
This network shows the impact of papers produced by Alex Dipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alex Dipper. The network helps show where Alex Dipper may publish in the future.
Co-authors
The 7 scholars most cited alongside Alex Dipper, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2021 | 411 |
| 2 | Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial Hit paper breakdown → | 2021 | 393 |
| 3 | Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2022 | 282 |
| 4 | Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis Hit paper breakdown → | 2022 | 231 |
| 5 | 2021 | 213 | |
| 6 | Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial Hit paper breakdown → | 2023 | 84 |
| 7 | 2021 | 13 | |
| 8 | 2021 | 8 | |
| 9 | 2022 | 2 | |
| 10 | 2026 | 0 |
About Alex Dipper
Alex Dipper is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering, Waste Management and Disposal and Organic Chemistry, having authored 10 papers that have together received 1.6k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Pleural and Pulmonary Diseases (3 papers) and Occupational and environmental lung diseases (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (35 citations), Internal Medicine (27 citations), Statistics and Probability (45 citations) and Oncology (75 citations). Alex Dipper has collaborated with scholars based in United Kingdom, Vietnam and Nepal. Frequent co-authors include Nick A. Maskell, Anna C. Bibby, Amelia O. Clive, Hayley E. Jones, Nancy J Preston, Rahul Bhatnagar and Hugh G. Welch. Their work appears in journals such as The Lancet, Thorax, Cancers, European Respiratory Review and Archivos de Bronconeumología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.